Kanaly Trust’s Novo Nordisk NVO Stock Holding History

Kanaly Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$8K	Sell	454 -66	-13%	-$1.2K	﹤0.01%	585
2016 Q3	$11K	Sell	520 -324	-38%	-$8.03K	﹤0.01%	518
2016 Q2	$23K	Sell	844 -76	-8%	-$2.08K	﹤0.01%	407
2016 Q1	$25K	Sell	920 -412	-31%	-$11K	0.01%	396
2015 Q4	$39K	Sell	1,332 -3,904	-75%	-$108K	0.01%	310
2015 Q3	$142K	Sell	5,236 -1,092	-17%	-$30.9K	0.03%	167
2015 Q2	$173K	Buy	6,328 +848	+15%	+$23.8K	0.03%	165
2015 Q1	$146K	Sell	5,480 -2,364	-30%	-$54.4K	0.03%	177
2014 Q4	$166K	Buy	7,844 +62	+0.8%	+$1.39K	0.03%	184
2014 Q3	$185K	Sell	7,782 -800	-9%	-$18.4K	0.04%	180
2014 Q2	$198K	Sell	8,582 -1,564	-15%	-$34.5K	0.04%	182
2014 Q1	$232K	Sell	10,146 -94	-0.9%	-$2K	0.05%	179
2013 Q4	$189K	Buy	+10,240	New	+$178K	0.04%	194

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Kanaly Trust's NVO Position: Q4 2016 in Review

Kanaly Trust reduced its Novo Nordisk (NVO) stake by 13% in Q4 2016, selling an estimated $1.2K and leaving 454 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Kanaly Trust first reported a position in NVO in Q4 2013 and has held it in 13 quarters since. The position peaked at $232K in Q1 2014. 482 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

Kanaly Trust held 454 shares of Novo Nordisk worth $8K as of Q4 2016.
Kanaly Trust sold 66 Novo Nordisk shares in Q4 2016, an estimated $1.2K.
Novo Nordisk made up ﹤0.01% of Kanaly Trust's portfolio in Q4 2016, its #585 holding.
Kanaly Trust first reported a position in Novo Nordisk in Q4 2013 and has held it in 13 quarters since.
Kanaly Trust's Novo Nordisk position peaked at $232K in Q1 2014.
482 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.